News
-
-
-
PRESS RELEASE
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range
PolyPeptide Group reports +24% revenue growth in H1 2025, revises full-year guidance towards upper range. EBITDA improved to EUR 4.4 million, major investments in capacity expansion projects -
-
-
PRESS RELEASE
PolyPeptide announces expansion of existing credit facilities
PolyPeptide Group AG secures EUR 40 million additional financing under existing credit facilities, supported by main shareholder Draupnir Holding B.V., enhancing financial flexibility for growth towards doubling revenue by 2028 -
-
-
-